Charles River Laboratories | CRL - Ebit


Charles River Laboratories reported $119.89M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Agilent USD 444M 45M Jun/2026
Align Technology USD 193.04M 1.72M Sep/2026
Bio-Rad Laboratories USD 72.6M 750.1M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Cardinal Health USD 814M 47M Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Cigna USD 2.76B 583M Mar/2026
Concord Medical Services Hldg CNY -94.68M 49.97M Dec/2025
CVS Health USD 6.73B 2.05B Jun/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 84M 52M Jun/2026
Elevance Health USD 2.15B 149M Sep/2026
Humana USD 1.36B 394M Jun/2026
Illumina USD 260M 21M Jun/2026
Incyte USD -707.47M 1.41B Sep/2026
Intrexon USD -26.3M 2.91M Jun/2024
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Lonza CHF 673M 54M Jun/2025
McKesson USD 1.42B 415M Jun/2026
Merck EUR 1.1B 51M Jun/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Novartis USD 4.73B 549M Jun/2026
Pfizer USD -180M 5.16B Jun/2026
Quest Diagnostics USD 479M 20M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
United Therapeutics USD 375.6M 49.8M Jun/2026
UnitedHealth USD 6.34B 1.65B Sep/2026
Veradigm USD -45.47M 70.47M Dec/2022
Waters USD 10M 138M Jun/2026
West Pharmaceutical Services USD -199.7M 378.8M Sep/2026